<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00829478</url>
  </required_header>
  <id_info>
    <org_study_id>Fried0011</org_study_id>
    <nct_id>NCT00829478</nct_id>
  </id_info>
  <brief_title>Improving the Quality of Care for Atrial Fibrillation by Promoting Patient-Centered Decision Making</brief_title>
  <acronym>AFIB</acronym>
  <official_title>Improving Quality of Care for Atrial Fibrillation by Promoting Patient-Centered Decision Making</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Connecticut Healthcare System</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Donaghue Medical Research Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Yale University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>VA Connecticut Healthcare System</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary aim of this proposal is to determine the effectiveness of a decision support tool&#xD;
      on improving the process of shared decision-making for treatment on nonvalvular atrial&#xD;
      fibrillation (NVAF) compared to receipt of usual care.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Decision-making regarding appropriate therapy for non-valvular atrial fibrillation (NVAF) is&#xD;
      a complex process. Different options carry with them different profiles of risks and&#xD;
      benefits, and choosing the &quot;right&quot; therapy depends upon the patient's understanding of these&#xD;
      risks and benefits and a consideration of the risks and benefits according to the patient's&#xD;
      values and preferences. Studies have shown that patients' preferred therapy frequently&#xD;
      disagrees with what is recommended by disease management guidelines.&#xD;
&#xD;
      The purpose of this study is to examine an intervention to improve the quality of&#xD;
      decision-making for NVAF compared to usual care. The intervention has several components,&#xD;
      including: a) educating the patient about why values and preferences are important to the&#xD;
      decision-making process, b) providing an individualized assessment of the risks and benefits&#xD;
      of each of the treatment options, c) exploring patients' values and preferences as they&#xD;
      relate to the risks and benefits of each of the treatment options, d) preparing the patient&#xD;
      to discuss his/her preferences with the physician.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2008</start_date>
  <completion_date type="Actual">June 2010</completion_date>
  <primary_completion_date type="Actual">May 2010</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Decisional conflict</measure>
    <time_frame>Immediately following and 1-month post-intervention</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Knowledge regarding atrial fibrillation</measure>
    <time_frame>Immediately following study intervention and 1 month post-intervention</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anxiety</measure>
    <time_frame>Immediately following intervention and 1 month post-intervention</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in treatment plan for atrial fibrillation</measure>
    <time_frame>Within 30 days post-intervention</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of clinician-patient communication</measure>
    <time_frame>Clinician visit immediately post-intervention</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">135</enrollment>
  <condition>Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Usual Care</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Decision Aid for Atrial Fibrillation</intervention_name>
    <description>Single contact educational session</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Usual Care</intervention_name>
    <description>Usual Care</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  45 years or older&#xD;
&#xD;
          -  Be scheduled to see primary Doctor at VA&#xD;
&#xD;
          -  Diagnosis of atrial fibrillation&#xD;
&#xD;
          -  English speaking&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Have valvular disease as the cause of Afib&#xD;
&#xD;
          -  Be on warfarin for a condition other than NVAF&#xD;
&#xD;
          -  Have a contraindication to warfin&#xD;
&#xD;
          -  Have a contraindication to ASA&#xD;
&#xD;
          -  Life expectancy of less than 12 months&#xD;
&#xD;
          -  Cognitive impairment&#xD;
&#xD;
          -  Receiving anti-platelet agent other than aspirin&#xD;
&#xD;
          -  Receiving care in a supervised resident clinic or from an attending physician who&#xD;
             refuses participation in the study&#xD;
&#xD;
          -  Bleed with identified source in the last 12 months&#xD;
&#xD;
          -  Bleed with an unidentified source&#xD;
&#xD;
          -  History of intracerebral hemorrhage&#xD;
&#xD;
          -  Severe hearing impairment&#xD;
&#xD;
          -  Severe visual impairment&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Terri R Fried, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>VA Connecticut HS</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>VA Connecticut Healthcare System - West Haven Campus</name>
      <address>
        <city>West Haven</city>
        <state>Connecticut</state>
        <zip>06516</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2012</verification_date>
  <study_first_submitted>January 24, 2009</study_first_submitted>
  <study_first_submitted_qc>January 26, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 27, 2009</study_first_posted>
  <last_update_submitted>March 16, 2012</last_update_submitted>
  <last_update_submitted_qc>March 16, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 20, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Atrial fibrillation</keyword>
  <keyword>Cerebrovascular accident</keyword>
  <keyword>Anticoagulation</keyword>
  <keyword>Decision-making</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

